Clinical Trial Update: Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of atezolizumab and bevacizumab with proton radiotherapy for unresectable hepatocellular carcinoma. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Hepatocellular Carcinoma Non-resectable | Phase 2 | Status: RECRUITING